Skip to main content
. 2019 Nov-Dec;35(6):1680–1686. doi: 10.12669/pjms.35.6.771

Fig. 3.

Fig. 3

The effect of comparing the results of different control measures.

Abbreviations: Placebo: A, Belimumab: B, Atacicept: C, Epratuzumab: D, Tabalumab: E, Rituximab: F, Blisibimod: G